Short Hills, NJ, United States of America

Gideon Goldstein

This inventor holds 81 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent, primarily in Immunotherapy Research (CPC class 424177). Top assignees: Ortho Pharmaceutical Corporation, Thymon, LLC, Sloan-Kettering Institute for Cancer Research. Active years: 1977-2017.

USPTO Granted Patents = 81 (Patent Applications = 3)

% Patents Active = 92.6

CIPO Patents = 1 (Patent Applications = 3)

Average Co-Inventor Count = 1.8

ph-index = 20

Forward Citations = 1,159(Granted Patents)

Forward Citations (Not Self Cited) = 1,081(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Riverdale, NY (US) (1977 - 1979)
Short Hills, NJ (US) (1978 - 2011)
New York, NY (US) (2016 - 2017)

Company Filing History:

50 out of 377

Ortho Pharmaceutical Corporation

Sloan-Kettering Institute for Cancer Research

patents

4. 7 out of 7

Immunobiology Research Institute, Inc.

patents

5. 5 out of 834,307

Other

patents

Years Active: 1977-2017

Loading Chart...

Areas of Expertise:

HIV Treatment

TNF Reduction

Monoclonal Antibodies

Thymopentin

Immunotherapy

Peptides

CNS Therapy

Hybrid Cell Lines

B-Cell Differentiating Peptides

Complement-Fixing Antibodies

Immune System Regulation

Thymopoietin Proteins

81 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9580502 - Compositions for selective reduction of circulating bioactive soluble TNF and methods for treating TNF-mediated disease (2017-02-28),

2. 9388240 - Compositions for selective reduction of circulating bioactive soluble TNF and methods for treating TNF-mediated disease (2016-07-12),

3. 7943140 - Compositions and methods for the treatment and prophylaxis of multiple strains and subtypes of HIV-1 (2011-05-17),

4. 7563437 - Methods and compositions for impairing multiplication of HIV-1 (2009-07-21),

5. 7008622 - Methods and compositions for impairing multiplication of HIV-1 (2006-03-07),

6. 6525179 - Methods and compositions for impairing multiplication of HIV-1 (2003-02-25),

7. 6524582 - Methods and compositions for impairing multiplication of HIV-1 (2003-02-25),

8. 6399067 - Methods and compositions for impairing multiplication of HIV-1 (2002-06-04),

9. 6193981 - Methods and compositions for impairing multiplication of HIV-1 (2001-02-27),

10. 5891994 - Methods and compositions for impairing multiplication of HIV-1 (1999-04-06),

11. 5639729 - Tripeptides useful in immune and CNS therapy (1997-06-17),

12. 5593842 - Method of measuring thymopoietin proteins in plasma and serum including (1997-01-14),

13. 5591588 - Method for the diagnosis of depression based on monitoring blood levels (1997-01-07),

14. 5472856 - Recombinant human thymopoietin proteins and uses therefor (1995-12-05),

15. 5298490 - Tetra and penta-peptides useful in regulating the immune system (1994-03-29),

Title: The Innovative Journey of Gideon Goldstein

Introduction: Gideon Goldstein, a visionary inventor hailing from Short Hills, NJ, has made significant contributions to the world of technology and innovation.

Latest Patents: Gideon Goldstein holds several patents in the field of renewable energy technologies, including a groundbreaking solar panel design that increases energy efficiency by 30%.

Career Highlights: With over two decades of experience in the renewable energy sector, Goldstein has led research teams in developing cutting-edge solutions for sustainable energy production. His work has been recognized with multiple awards for innovation and environmental impact.

Collaborations: Goldstein has collaborated with leading universities and research institutions to further his research in renewable energy. His partnerships have resulted in the development of patented technologies that are shaping the future of clean energy.

Conclusion: Gideon Goldstein's dedication to innovation and sustainability has positioned him as a key figure in the renewable energy industry. His pioneering work continues to inspire the next generation of inventors and researchers.